ABBVIE WKN: A1J84E ISIN: US00287Y1091 Kürzel: ABBV Forum: Aktien Thema: Hauptdiskussion

Quelle seekingalpha.com

Wells Fargo has selected Abbvie (NYSE:ABBV) as its top pick among large biotech and major pharma sectors. The firm is initiating coverage with an overweight rating and a $165 price target (~35% upside based on yesterday's close). Analyst Mohit Bansal says that Abbvie's business other than Humira is underappreciated. "This business is growing at 10% rev and 20% EPS CAGR and is already 30% bigger vs. [Eli Lilly (NYSE:LLY)] but trading at >50% discount to LLY," he writes. Bansal adds that concerns over patent expiration for Humira is hiding the the value and growth of the rest of the business. He also notes that a concerns over a recent label change for Rinvoq on sales of the product are overblown as this update was largely expected

https://www.reuters.com/business/healthcare-pharmaceuticals/jury-hear-final-arguments-ny-opioid-case-against-drugmakers-2021-12-08/

https://finance.yahoo.com/news/upadacitinib-rinvoq-achieved-primary-key-133000723.html AbbVie (NYSE: ABBV) today announced positive top-line results from U-EXCEED, a Phase 3 induction study, showing upadacitinib (45 mg once daily) achieved both p...

Hallo Connie wenn ich den Kurs von Abbvie sehe scheint die Meldung die Börse nicht zu interessieren.

https://seekingalpha.com/news/3777094-abbvie-updates-us-labeling-info-for-rinvoq-in-rheumatoid-arthritis?source=copy_to_clipboard

Wie schätzt ihr diese Meldung ein? 🤔 https://www.reuters.com/business/healthcare-pharmaceuticals/fda-warns-increased-heart-related-issues-pfizers-arthritis-drug-xeljanz-2021-12-03/

Auch mit an Bord 🙋🏼‍♂️. Die Aktie klingt sehr interessant, hoffe die macht auch viel Freude 👆🏻

https://marijuanastocks.com/abbv-submits-application-for-risankizumab-skyrizi-in-moderate-to-severe-crohns-disease/?amp

Nur blöd, dass nicht alle Aktien im Depot so laufen können :)

Top Aktie mit Top Dividende. Gekauft um lange liegen zu lassen 👍 ein Goldstück

AbbVie Inc. (NASDAQ: ABBV): Societe Generale upgraded the pharmaceutical leader from Hold to Buy with a gigantic $172 price target. The consensus target is just $128.32. Monday’s final print was reported at $115.65.

Tolle Aktie

Bin auch zufrieden auch wenn ich erst seit März 2020 dabei bin

Ich hatte Abbvie schon lange bevor BH sie kauften und meinetwegen machen die was sie wollen. Top Aktie-Top Unternehmen 😘👍